These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6435949)

  • 21. Captopril.
    Ram CV
    Arch Intern Med; 1982 May; 142(5):914-6. PubMed ID: 6282230
    [No Abstract]   [Full Text] [Related]  

  • 22. [Captopril (Capoten). A new antihypertensive agent blocking the renin-angiotensin system].
    Rasmussen S; Jensen G; Giese J
    Ugeskr Laeger; 1983 May; 145(22):1695-9. PubMed ID: 6349075
    [No Abstract]   [Full Text] [Related]  

  • 23. Antihypertensive and renal effects of captopril in relation to renin activity and bradykinin-induced vasodilation.
    Kiowski W; van Brummelen P; Hulthén L; Amann FW; Bühler FR
    Clin Pharmacol Ther; 1982 Jun; 31(6):677-84. PubMed ID: 7042175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Captopril in the treatment of hypertension.
    Staessen J; Fagard R; Lijnen P; Amery A
    Acta Clin Belg; 1982; 37(3):164-84. PubMed ID: 6214916
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical improvement and hormonal changes in severe cardiac failure after captopril treatment.
    McGrath BP; Denham IM; Johnston CI
    Aust N Z J Med; 1981 Dec; 11(6):639-44. PubMed ID: 6277291
    [No Abstract]   [Full Text] [Related]  

  • 26. Converting enzyme inhibition in mild and moderate essential hypertension. I. Acute effects on blood pressure, the renin-angiotensin system and blood bradykinin after a single dose of captopril.
    Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
    Acta Med Scand; 1985; 218(5):435-42. PubMed ID: 3004113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Captopril - profile of a new antihypertensive (author's transl)].
    Gross F
    MMW Munch Med Wochenschr; 1981 Nov; 123(47):1803-9. PubMed ID: 6796855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for the role of kinins in the acute antihypertensive effect of captopril in low-renin hypertension.
    Mizuno K; Haruyama K; Gotoh M; Matsui J; Fukuchi S
    Jpn Heart J; 1984 May; 25(3):379-86. PubMed ID: 6381785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.
    Johnston CI; Clappison B; McGrath BP; Matthews PG; Millar JA; Anderson WP
    Prog Biochem Pharmacol; 1980; 17():123-33. PubMed ID: 6259649
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of captopril on arterial pressure, systemic hemodynamics and renin activity in the blood plasma of rats with spontaneous hypertension].
    Pinelis VG; Vakulina TP; Poliak MG; Markov KhM
    Kardiologiia; 1988 Jan; 28(1):66-70. PubMed ID: 3282117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.
    Hosoki K; Takeyama K; Minato H; Fukuya F; Kawahara S; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):77-83. PubMed ID: 3006712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of captopril in experimental low renin hypertension.
    Tikkanen I; Fyhrquist F; Tikkanen T; Miettinen A
    Eur J Pharmacol; 1980 Nov; 68(2):197-200. PubMed ID: 7009165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical applications of angiotensin-converting enzyme inhibitors.
    Ferguson RK; Vlasses PH; Rotmensch HH
    Am J Med; 1984 Oct; 77(4):690-8. PubMed ID: 6091446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Captopril: clinical pharmacology and benefit-to-risk ratio in hypertension and congestive heart failure.
    Vlasses PH; Ferguson RK; Chatterjee K
    Pharmacotherapy; 1982; 2(1):1-17. PubMed ID: 6765388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of subacute oral administration of captopril (SQ 14,255) on the renin-angiotensin system in spontaneously hypertensive rats.
    Pong SF; Moore AF; Huang CT; Ellis KO
    J Pharm Pharmacol; 1982 Mar; 34(3):186-7. PubMed ID: 6121897
    [No Abstract]   [Full Text] [Related]  

  • 36. Renin- and non-renin-mediated antihypertensive actions of converting enzyme inhibitors.
    Zusman RM
    Kidney Int; 1984 Jun; 25(6):969-83. PubMed ID: 6088887
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of captopril in circulatory failure].
    Mareev VIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):109-14. PubMed ID: 6753872
    [No Abstract]   [Full Text] [Related]  

  • 38. [Captopril--mechanisms of action and its use in the treatment of arterial hypertension].
    Raszewska J; Bar-Andziak E
    Pol Arch Med Wewn; 1986 Mar; 75(3):225-31. PubMed ID: 3532047
    [No Abstract]   [Full Text] [Related]  

  • 39. [Angiotensin converting enzyme--captopril].
    Kaneko Y; Shionoiri H; Uneda S; Fujishima S
    Nihon Rinsho; 1979 Oct; 37(10):3492-8. PubMed ID: 392136
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of the hormonal and renal effects of captopril in severe essential and renovascular hypertension.
    Aldigier JC; Plouin PF; Guyene TT; Thibonnier M; Corvol P; Menard J
    Am J Cardiol; 1982 Apr; 49(6):1447-52. PubMed ID: 7041584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.